Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«National Institute of Oncology

Below is an extended National Institute of Oncology news listing. Click here to return to the National Institute of Oncology main Biocorporate entry.

BioNews Results for National Institute of Oncology:
Carmel Pharma Introduces PhaSeal? Secondary Set (C60) Entrepreneur.com: Nov 2 2009 2:39AM Matching: national institute oncology
Carmel Pharma Introduces PhaSeal, Secondary Set (C60) Therapeutics Daily: Nov 1 2009 1:26PM Matching: national institute oncology
Carmel Pharma Introduces PhaSeal Secondary Set (C60) Prudent Press Agency: Nov 1 2009 4:07PM Matching: national institute oncology
Carmel Pharma Introduces PhaSeal Secondary Set (C60) PRWeb: Nov 1 2009 1:04PM Matching: national institute oncology
Carmel Pharma Introduces PhaSeal Secondary Set (C60) PR.com: Nov 1 2009 12:27PM Matching: national institute oncology
Carmel Pharma Introduces PhaSeal Secondary Set (C60) Pharmacy Choice: Nov 1 2009 10:38AM Matching: national institute oncology
Carmel Pharma Introduces PhaSeal Secondary Set (C60) PRWeb: Nov 1 2009 4:27AM Matching: national institute oncology
Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatmen Journal of Clinical Oncology: Oct 31 2009 5:51PM Matching: national institute oncology
Costs and Benefits of the National Cancer Institute Central Institutional Review Board [Economic Analysis] Journal of Clinical Oncology: Oct 31 2009 5:50PM Matching: national institute oncology
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recu Journal of Clinical Oncology: Oct 31 2009 5:49PM Matching: national institute oncology
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Journal of Clinical Oncology: Oct 31 2009 5:52PM Matching: national institute oncology
Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Journal of Clinical Oncology: Oct 31 2009 5:49PM Matching: national institute oncology
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients Journal of Clinical Oncology: Oct 31 2009 5:47PM Matching: national institute oncology
Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Col Journal of Clinical Oncology: Oct 31 2009 5:51PM Matching: national institute oncology
Physician Referral for Fertility Preservation in Oncology Patients: A National Study of Practice Behaviors [He Journal of Clinical Oncology: Oct 31 2009 5:48PM Matching: national institute oncology

«National Institute of Oncology

This page contained an extended National Institute of Oncology news listing. Click here to return to the National Institute of Oncology main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.